| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/11/2000 | US6087116 Interleukin-18 (IL-18) receptor polypeptides and their uses |
| 07/11/2000 | US6087110 Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
| 07/11/2000 | US6087109 Antisense agent which associated with a heat stable toxin receptor; for diagnosis and prevention of intestinal cancers in humans; anticarcinogenic agents . |
| 07/11/2000 | US6087108 Detecting a polynucleotide sequence coding a polypeptide; hybridizing polynucleotide to nucleic acid in sample, form and detect hybrid, presence of hybrid is indicative of polynucleotide coding polypeptide |
| 07/11/2000 | US6087107 Therapeutics and diagnostics for congenital heart disease based on a novel human transcription factor |
| 07/11/2000 | US6087106 Nucleic acids conferring and inducible resistance to glycopeptides particularly in gram-positive bacteria |
| 07/11/2000 | US6087091 Detection of a compound for pain reduction; monitoring the activity of test compound in blocking calcium channels, binding conotoxin binding positions and suppression norepinephrine release from nervous tissue |
| 07/11/2000 | US6087087 Treatment of hemoglobin with nitric oxide |
| 07/11/2000 | US6086919 Pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound |
| 07/11/2000 | US6086918 Releasing peptide active agent, with ph lowering agent and an absorption enhancer into patient's intestine through mouth and stomach under protection of an acid resistant vehicle which prevents contact between stomach protease and peptide |
| 07/11/2000 | US6086898 Administering listeria adjuvants and antigens for immunology |
| 07/11/2000 | US6086897 Isolation peptide from a protein allergen of dermatophagoide |
| 07/11/2000 | US6086895 Treatment with proteins and polypeptides |
| 07/11/2000 | US6086891 Plasmids |
| 07/11/2000 | US6086886 Composition for promoting intestinal health |
| 07/11/2000 | US6086885 Anti-bacterial protein extracts from seeds of marigold and paprika |
| 07/11/2000 | US6086879 Antibody to the syncytiotrophoblast antigen R80K and use thereof |
| 07/11/2000 | US6086877 Therapeutic agent for rheumatic disease |
| 07/11/2000 | US6086876 Suppressing interleukin-12 (il-12) production in a human by administering a ligand that binds the complement receptor protein cd46, the ligand suspended in a carrier and binding suppresses il-12 production; treating autoimmune diseases |
| 07/11/2000 | US6086874 Kit comprising an interleukin-6 (il-6) antagonist such as antibody to il-6, antibody to il-6 receptor, and antibody to gp130 protein, an antitumor agent such as cisplatin, and a carrier; antagonist and antitumor agent not physically bonded |
| 07/11/2000 | US6086872 Relief from the hand contracture of dupuytren's disease by injecting collagenase into the fibrous dupuytren's cord, immobilizing the hand immediately after injection, and maintaining it immobile for several hours |
| 07/11/2000 | US6086871 Prothrombin derivatives |
| 07/11/2000 | US6086869 Particularly cystoid macular edema |
| 07/11/2000 | US6086868 Method for treating or preventing ischemia-reperfusion injury |
| 07/11/2000 | US6086867 By contacting the cell with a soluble polypeptide comprising the amino acid sequence of the extracellular domain of the transforming growth factor-beta (tgf-b) type iii receptor protein or mammalian dna encoding it |
| 07/11/2000 | US6086866 Anastomosing divided blood vessels in a human or animal by administering around the divided ends of the blood vessels, platelet derived growth factor |
| 07/11/2000 | US6086865 O-chloracetylcarbamoylfumagillol and interferon; synergistic angiogenesis inhibitory effect |
| 07/11/2000 | US6086850 Calcitonin receptor binding reagents |
| 07/11/2000 | US6085753 Insulin delivery enhanced by coached breathing |
| 07/11/2000 | CA2208569C Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
| 07/11/2000 | CA2162600C Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions |
| 07/11/2000 | CA2082948C Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding |
| 07/11/2000 | CA2079912C Hepatitis c virus epitopes |
| 07/11/2000 | CA1341051C Crf antagonists |
| 07/11/2000 | CA1341050C Neurite growth regulatory factors |
| 07/11/2000 | CA1341048C Method and compositions for making acsf and acsf antagonists |
| 07/06/2000 | WO2000039327A1 Peptidoglycan recognition proteins |
| 07/06/2000 | WO2000039315A1 Ucp-2 promoter and use thereof |
| 07/06/2000 | WO2000039304A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 07/06/2000 | WO2000039302A2 Improved expression of hiv polypeptides and production of virus-like particles |
| 07/06/2000 | WO2000039299A2 Streptococcus antigens |
| 07/06/2000 | WO2000039298A1 Chimeric gene encoding the antigenic determinants of four proteins of l. infantum |
| 07/06/2000 | WO2000039295A1 Member of the tnf ligand family |
| 07/06/2000 | WO2000039293A2 Agent for inhibiting the regeneration of tissue |
| 07/06/2000 | WO2000039292A2 Antisense oligonucleotide for inhibiting the expression of the adhesion molecule very late antigen 4 (vla-4) in human cells |
| 07/06/2000 | WO2000039290A2 Pharmaceutical formulation containing a microbial enzyme which digests hyaluronic acid |
| 07/06/2000 | WO2000039287A2 A. fumigatus acetyl coenzyme-a carboxylase genes and polypeptides and uses thereof |
| 07/06/2000 | WO2000039285A2 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof |
| 07/06/2000 | WO2000039283A1 Use of cd40 engagement to alter t cell receptor usage |
| 07/06/2000 | WO2000039280A2 Leukocyte-derived interferon preparations |
| 07/06/2000 | WO2000039278A2 Pth functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules |
| 07/06/2000 | WO2000039277A2 Ndsp nucleic acids and polypeptides |
| 07/06/2000 | WO2000039165A1 Serine protease inhibitor |
| 07/06/2000 | WO2000039161A1 Class ii cytokine receptor-like proteins and nucleic acids encoding them |
| 07/06/2000 | WO2000039160A2 Caspase-8 interacting proteins |
| 07/06/2000 | WO2000039159A1 Superantigens |
| 07/06/2000 | WO2000039158A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | WO2000039157A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | WO2000039156A1 Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 07/06/2000 | WO2000039155A1 PENICILLINS AS PHARMACEUTICALS FOR THE DOWNREGULATION OF IFNη PRODUCTION |
| 07/06/2000 | WO2000039154A2 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension |
| 07/06/2000 | WO2000039153A1 Pseudopeptide compounds having an inhibiting activity with respect to paths activated by proteins with active tyrosine kinase activity and pharmaceutical compositions containing same |
| 07/06/2000 | WO2000039152A1 Stable subtilin and methods of manufacture |
| 07/06/2000 | WO2000039149A2 Secreted proteins and uses thereof |
| 07/06/2000 | WO2000039136A2 Human brainiac-5 |
| 07/06/2000 | WO2000039129A1 Immunosuppressive effects of pteridine derivatives |
| 07/06/2000 | WO2000039124A1 Thrombin inhibitors |
| 07/06/2000 | WO2000039119A1 Novel inhibitors of farnesyl-protein transferase |
| 07/06/2000 | WO2000038786A2 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000038747A2 Absorbent article composition and method of use for sequestering skin irritants |
| 07/06/2000 | WO2000038743A1 Removal of biological contaminants |
| 07/06/2000 | WO2000038737A2 GENE THERAPY FOR PULMONARY EDEMA USING ADENOVIRUS VECTORS ENCODING Na,K-ATPase |
| 07/06/2000 | WO2000038733A1 Peptidic product, process and composition |
| 07/06/2000 | WO2000038732A1 Hyaluronate lyase used for promoting penetration in topical agents |
| 07/06/2000 | WO2000038730A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
| 07/06/2000 | WO2000038719A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | WO2000038718A2 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia |
| 07/06/2000 | WO2000038717A2 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 07/06/2000 | WO2000038715A2 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 07/06/2000 | WO2000038713A1 Agonists or antagonists of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 07/06/2000 | WO2000038709A1 Treatment of hyperproliferative disorders using casein kinase i |
| 07/06/2000 | WO2000038708A1 Treatment and prevention of immune rejection reactions |
| 07/06/2000 | WO2000038707A1 Method for the treatment of bone loss |
| 07/06/2000 | WO2000038706A2 Methods for treating cancer and for mediating chemotaxis of dendritic cells |
| 07/06/2000 | WO2000038705A1 Protection of hematopoietic cells by the induction of post-mitotic quiescence |
| 07/06/2000 | WO2000038704A1 Use of peptide |
| 07/06/2000 | WO2000038703A1 Agent for treating visual cell function disorder |
| 07/06/2000 | WO2000038702A1 Cyclosporin solution |
| 07/06/2000 | WO2000038680A1 Azabicycloalkanes as ccr5 modulators |
| 07/06/2000 | WO2000038665A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000038655A1 Dosage forms comprising porous particles |
| 07/06/2000 | WO2000038654A1 Synthetic and therapeutic methods for the alpha and beta domains of metallothionein |
| 07/06/2000 | WO2000038652A1 Polyol/oil suspensions for the sustained release of proteins |
| 07/06/2000 | WO2000038651A1 BIODEGRADABLE pH/THERMOSENSITIVE HYDROGELS FOR SUSTAINED DELIVERY OF BIOLOGICALLY ACTIVE AGENTS |
| 07/06/2000 | WO2000038626A2 Substrate composition and method of use for sequestration of skin irritants |
| 07/06/2000 | WO2000038625A2 Facial tissue composition and method of use for sequestration of nasal secretion skin irritants |
| 07/06/2000 | WO2000038535A1 Food-induced antisecretory proteins in egg yolk |
| 07/06/2000 | WO2000038518A1 Efficient and stable (in vivo) gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors |
| 07/06/2000 | WO2000038517A1 Methods for reducing adverse side effects associated with cellular transplantation |
| 07/06/2000 | WO2000038515A1 Peptide mimics useful for treating disease |